1. Home
  2. Insights
  3. Articles

Preparing Your Life Sciences Workforce for Next-Generation Therapies

Connect With An Expert
Pharmacy professionals use specialized life sciences staffing for emerging therapies like GLP-1.
Learn how to utilize specialized life sciences staffing to capitalize on the growing demand for emerging therapies like GLP-1 and personalized medicine.

Pharmaceutical and biotechnology innovation is accelerating across high-growth areas such as GLP-1 therapies, oncology, radiopharmaceuticals and personalized medicine. Each category is reshaping how therapies are developed, manufactured and commercialized, creating new opportunities for organizations that can scale capabilities alongside growth.

While each area presents unique workforce requirements, organizations that align talent strategies with pipeline, manufacturing and commercialization plans will be better positioned to capitalize on growth opportunities. The workforce implications differ significantly across these therapy areas. GLP-1 expansion is driving manufacturing scale, oncology demands modality-specific expertise, and personalized medicine increasingly relies on interdisciplinary skill sets. This forward-looking approach is especially important in pharma and biotech, where lengthy development timelines and talent shortages can delay progress and impact speed to market.

Read more about the cutting-edge category impacting your organization the most:
GLP-1OncologyPersonalized Medicine

GLP-1 Manufacturing Growth Scales Need for Life Sciences Staffing

Continued GLP-1 category growth is creating opportunities to expand biopharmaceutical manufacturing capacity and bring therapies to market faster. Manufacturers are investing heavily in new facilities, production lines and technology transfers to meet growing demand. Organizations must ensure that the supporting capabilities are in place to scale effectively. As volume increases, pharmaceutical organizations can bring in specialized resources capable of maintaining quality and consistency while operations scale at unprecedented speeds.

To prepare, life sciences companies should map workforce demand to planned capacity increases, line expansions, technology transfers and product milestones. When forecasting headcount for GLP-1 manufacturing initiatives, account for the entire production ecosystem — validation, quality control testing, environmental monitoring, documentation — rather than manufacturing operations alone.

GLP-1 expansion often creates workforce needs beyond manufacturing roles alone. Organizations may need additional validation, quality, technical operations and regulatory expertise to support successful scale-up. Identifying those capability requirements early can help ensure capacity investments deliver their intended business impact.

Oncology Expansion Raises the Premium on Specialized Pharmaceutical Staffing

The oncology space is increasingly defined by a diverse range of next-generation approaches rather than a single development or manufacturing model. Radiopharmaceuticals are an especially important area of growth leading to increased demand for specialized handling, production and quality expertise. As therapeutic approaches diversify, organizations can no longer rely on broad pharmaceutical experience alone. Success increasingly depends on access to talent with expertise aligned to specific modalities, technologies and regulatory environments.

While Actalent is seeing a continued competitive market for skilled STEM talent, in oncology, success often depends less on finding additional talent and more on identifying professionals with experience relevant to a specific modality. A strong general pharma background may not substitute for expertise with the processes, technologies or controls associated with a particular therapeutic platform.

Redefining “Qualified” in Oncology Staffing

As oncology therapies become increasingly specialized, organizations should develop a more precise definition of what makes a candidate qualified for a specific role. Hiring criteria should align with the modality, stage of development, regulatory requirements and operational environment involved. In many cases, defining the right expertise upfront is more important than simply increasing the number of candidates in the pipeline.

Questions to consider include:

  • Which modality does the candidate need to be experienced in?
  • At what point in development or manufacturing should they work?
  • Which regulatory or compliance standards do they need to be familiar with?
  • At what level of scale and complexity should they be experienced in?

Taking this approach can help organizations focus their searches on candidates with the most relevant experience for the work at hand.

Personalized Medicine Relies on Interdisciplinary Pharma Roles

Recent expansion in personalized medicine connects disciplines that may have historically operated separately. Bioinformatics, biomarkers, genomics, clinical expertise and data science capabilities are converging. Personalized medicine is reshaping what "qualified talent" looks like. Organizations increasingly require professionals who can bridge scientific, clinical and data-driven disciplines that have traditionally operated in separate functions.

These combinations can create hybrid roles that do not map neatly to traditional job descriptions. For example, a personalized medicine program may require professionals who can interpret genomic data, collaborate with clinical teams and support biomarker-driven decision-making. These blended skill sets can be more difficult to source through traditional hiring approaches.

Successfully hiring for personalized medicine initiatives often requires looking beyond traditional job titles and career paths. Candidates may bring relevant expertise from adjacent disciplines, making transferable skills and cross-functional experience important evaluation criteria. Actalent can help organizations identify professionals with the combination of scientific, clinical and technical competencies needed to support these evolving programs.

Strategic Workforce Planning Helps Life Science Teams Capitalize on Growth

When organizations know months in advance that a GLP-1, oncology or personalized medicine program is approaching a milestone, that pipeline visibility is an opportunity to forecast where specialized life sciences talent will be required. The most successful organizations treat talent strategy as a business-readiness exercise, aligning workforce decisions with anticipated manufacturing, development and commercialization needs. Organizations that connect talent planning to key business milestones are often better positioned to respond to changing business needs.

Partner with Actalent to Build a Workforce Aligned to Life Sciences Growth

Biotech and pharma demands and production plans change faster than permanent workforce structures ever can. But as life sciences innovation evolves, the workforce behind it needs to evolve too.

Getting a life sciences staffing plan in place for fast-moving projects requires clarifying the kinds of team members that are truly needed. Actalent can guide companies in categorizing:

  • Capabilities that represent sustained, long-term demand
  • Expertise tied to a defined expansion or validation project
  • Surge support needed during fast-moving scale-up initiatives

Actalent has extensive experience supporting projects spanning new drug development and manufacturing, method development/transfer/validation, new manufacturing-line validation and central lab scale-up. Our talent network can help your life sciences organization find flexible staffing or project-based support to seamlessly add capacity purpose-built for GLP-1, oncology or personalized medicine initiatives.

Contact us to find specialized talent as your organization’s next-generation life sciences projects ramp up.

Frequently Asked Questions About
Life Sciences Staffing and Talent Readiness

Pharmaceutical companies can prepare for manufacturing expansion by assessing the full range of required capabilities and hiring specialized life sciences staffing before new lines or facilities are activated. Planning early helps ensure the right talent is available to support equipment qualification, process scale-up, quality control and manufacturing operations as demand grows.

Workforce planning helps pharmaceutical companies scale up by aligning talent needs with production goals, project schedules and go-to-market timelines. It can also help teams determine where permanent hires, flexible staffing or project-based expertise makes the most sense as demand changes. By anticipating where specialized expertise will be needed, organizations can take advantage of industry growth and reduce the risk of capability gaps that would slow biopharmaceutical manufacturing, validation or quality activities.

Pharmaceutical companies should begin planning for future hiring needs as soon as future growth, pipeline activity or operational changes become visible. The earlier companies identify likely talent needs, the more time they have to compete for specialized professionals and prepare them to contribute when key initiatives ramp up.

When hiring specialized talent, pharmaceutical and biotechnology companies should prioritize skills that match the specific therapy, modality, process and operating environment involved. Depending on the work in the pipeline, that may include manufacturing, quality, validation or highly specialized scientific expertise, as well as interdisciplinary capabilities such as genomics, bioinformatics and data science.

Workforce planning helps pharmaceutical companies translate upcoming drug development milestones into specific talent requirements before a program reaches a critical transition point. That gives organizations more flexibility to add or scale the right capabilities as programs advance. However, the talent needs and milestones will vary depending on the life sciences initiative, such as GLP-1, oncology and radiopharmaceuticals, or personalized medicine therapies.

Ready to Hire Top Talent for Life Sciences Projects?

Partner with Actalent on your life sciences staffing needs.

Contact Us Today

Relevant Insights

  • Professional learning how pharmacy staffing shortages affect paitent safety.

    Article

    Why Proactive Pharmacy Staffing Is Essential to Patient Safety

    Learn how pharmacy staffing shortages affect patient safety, increase medication risks and drive burnout, and how proactive workforce planning can help.

    Read More
  • Healthcare professionals ensuring quality performance meaures are taken before and after the examination room.

    Article

    How Allied Healthcare Talent Staffing Protects Quality Scores

    Learn how flexible healthcare talent staffing models help protect CMS Star Ratings, patient care and financial stakes. Connect with Actalent.

    Read More
  • Biopharma expert following FDA compliance to increase efficiency.

    Article

    Speed vs. Compliance: How Biopharma Manufacturing Staffing Solutions Solve the Production Dilemma

    Balance throughput with FDA compliance. Discover how proactive biopharma manufacturing staffing solutions mitigate FDA risk without slowing production lines.

    Read More
View All Insights